Filing Details

Accession Number:
0001181431-14-025055
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-06-26 15:14:51
Reporting Period:
2014-06-24
Filing Date:
2014-06-26
Accepted Time:
2014-06-26 15:14:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1437402 Ardelyx Inc. ARDX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1005561 J Peter Barris 1954 Greenspring Drive
Suite 600
Timonium MD 21093
No No Yes No
1219855 James M Barrett 1954 Greenspring Drive
Suite 600
Timonium MD 21093
No No Yes No
1235112 J Patrick Kerins 1954 Greenspring Drive
Suite 600
Timonium MD 21093
No No Yes No
1237289 D Scott Sandell 1954 Greenspring Drive
Suite 600
Timonium MD 21093
No No Yes No
1270521 Kittu Krishna Kolluri 1954 Greenspring Drive
Suite 600
Timonium MD 21093
No No Yes No
1277631 Forest Baskett 1954 Greenspring Drive
Suite 600
Timonium MD 21093
No No Yes No
1302106 D Ryan Drant 1954 Greenspring Drive
Suite 600
Timonium MD 21093
No No Yes No
1383389 Nea 12 Gp, Llc 1954 Greenspring Drive
Suite 600
Timonium MD 21093
No No Yes No
1383390 Nea Partners 12, Limited Partnership 1954 Greenspring Drive
Suite 600
Timonium MD 21093
No No Yes No
1383391 New Enterprise Associates 12, Limited Partnership 1954 Greenspring Drive
Suite 600
Timonium MD 21093
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-06-24 1,415,642 $0.00 1,415,642 No 4 C Direct
Common Stock Acquisiton 2014-06-24 4,404,887 $0.00 5,820,529 No 4 C Direct
Common Stock Acquisiton 2014-06-24 216,573 $0.00 6,037,102 No 4 C Direct
Common Stock Acquisiton 2014-06-24 72,190 $0.00 6,109,292 No 4 C Direct
Common Stock Acquisiton 2014-06-24 510,442 $14.00 6,619,734 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2014-06-24 1,415,642 $0.00 1,415,642 $0.00
Common Stock Series B Preferred Stock Disposition 2014-06-24 4,404,887 $0.00 4,404,887 $0.00
Series B Preferred Stock Series B Preferred Stock Purchase Warrant Disposition 2014-06-24 217,975 $0.00 217,975 $0.09
Common Stock Series B Preferred Stock Acquisiton 2014-06-24 217,975 $0.00 217,975 $0.00
Common Stock Series B Preferred Stock Disposition 2014-06-24 1,402 $14.00 1,402 $0.00
Common Stock Series B Preferred Stock Disposition 2014-06-24 216,573 $0.00 216,573 $0.00
Series B Preferred Stock Series B Preferred Stock Purchase Warrant Disposition 2014-06-24 72,658 $0.00 72,658 $0.09
Common Stock Series B Preferred Stock Acquisiton 2014-06-24 72,658 $0.00 72,658 $0.00
Common Stock Series B Preferred Stock Disposition 2014-06-24 468 $14.00 468 $0.00
Common Stock Series B Preferred Stock Disposition 2014-06-24 72,190 $0.00 72,190 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
0 2020-11-16 No 4 X Direct
217,975 No 4 X Direct
216,573 No 4 J Direct
0 No 4 C Direct
0 2021-04-14 No 4 X Direct
72,658 No 4 X Direct
72,190 No 4 J Direct
0 No 4 C Direct
Footnotes
  1. Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into one share of Issuer's Common Stock upon the consummation of the Issuer's initial public offering (the "IPO").
  2. The shares are directly held by New Enterprise Associates 12, Limited Partnership ("NEA 12") and indirectly held by NEA Partners 12, Limited Partnership ("NEA Partners 12"), the sole general partner of NEA 12, NEA 12 GP, LLC ("NEA 12 GP"), the sole general partner of NEA Partners 12, and the individual managers of NEA 12 GP (NEA Partners 12, NEA 12 GP and the individual managers of NEA 12 GP together, the "NEA 12 Indirect Reporting Persons"). The individual managers of NEA 12 GP are M. James Barrett, Peter J. Barris, Forest Baskett, Ryan D. Drant, Patrick J. Kerins, Krishna "Kittu" Kolluri, and Scott D. Sandell. The NEA 12 Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 12 shares in which the NEA 12 Indirect Reporting Persons have no pecuniary interest.
  3. The expiration date is not relevant to the conversion of these securities.
  4. Immediately prior to the closing of the IPO, the warrants automatically net exercised by their terms into Series B Preferred Stock, which allowed the holder to pay the exercise price of the warrants by forfeiting a portion of the exercised warrant shares with a value equal to the aggregate exercise price.
  5. These shares reflect the net exercise of the preferred stock warrant pursuant to its terms into 216,573 shares of the Issuer's Series B Preferred Stock.
  6. These shares reflect the net exercise of the preferred stock warrant pursuant to its terms into 72,190 shares of the Issuer's Series B Preferred Stock.